Skip to content
X

Sight Diagnostics
Field: Blood diagnostics
Stage: Phase III
Status: Private
CEO: Yossi Pollack
Sight Diagnostics uses advanced computer-vision and machine-learning technology in the field of blood diagnostics. The company’s initial product, the Parasight platform, is a highly accurate, easy-to-use device for diagnosing malaria.
Sight Diagnostics is also applying its technology to the complete blood count (CBC) market, developing a point-of-care CBC platform which will provide a five-point differential blood count for use in doctors’ offices and emergency medical centers.
Press Releases
-
23Jul
-
18Mar
-
05Nov
-
11Apr
-
15Jul
-
24Jun
2020
2019
2018